South Wales, Sept. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "RELFYDESS" on Sept. 1. The details about the trademark application no. UK00004257349 published in the journal no. 2025/037 (Sept. 12).

With HGF Limited as representative, Galderma Holding SA filed the trademark application for the below mentioned good(s)/service(s).

Class 5 : Pharmaceutical preparations; pharmaceutical preparations containing neurotoxins; dermatological preparations; pre-filled syringes for medical purposes; injectable neurotoxins; medicated dermatological preparations and substances for the treatment of wrinkles, folds, scars, and lips, for face and body contour and skin rejuvenation; medicinal preparations for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; pharmaceutical preparations containing neurotoxins for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; injectable pharmaceutical products, namely, injectable dermal filler; injectable gels for use in the treatment and repair of joint cartilage; injectable dermal filler products, namely, injectable dermal fillers; pharmaceutical preparations containing neurotoxins for skin care; muscle relaxants; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, headaches, wrinkles, hyderhydrosis, and pain.

Class 10 : Medical devices, namely, implants consisting of artificial materials in gel form used for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; syringes for injections; injection devices for pharmaceutical products.

The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004257349

Disclaimer: Curated by HT Syndication.